WVXU: Genetics play a role in opioid addiction. A UC doctor is drilling down on the specifics
Research could lead to the creation of a test for opioid use disorder
Since 2014, Ohio is in the top five nationwide in opioid deaths. Recently published research from the University of Cincinnati examines the role of genetics in opioid use disorder. WVXU produced a story on the research, interviewing lead researcher, Caroline Freiermuth, MD, of the Department of Emergency Medicine at the UC College of Medicine. She and her team screened over 1,300 patients at three Ohio urban emergency rooms and found 20% had opioid use disorder.
The patients studied were at the ER for a variety of reasons. Some were already addicted to opioids, some had never taken them, and others were using them to manage acute pain. All of them were asked to be part of the study.
WVXU reported the 20% of people who had opioid use disorder is higher than what was previously thought — 2% in the general population and 7-15% in emergency room settings.
"This is still a hidden disease," Freiermuth says. "People are afraid to talk about it and we really do need to do a better job of screening so that we can identify the people who have already developed this disorder and really get them into the treatment they need."
For genetics, she looked at the dopamine reward pathway and the metabolism of opioids for the study.
Using artificial intelligence, her team is analyzing the entire data set, including things like the environment, mental health disorders, and past experiences to see what role they play.
"The biggest takeaway is this adds to the body of research that says there is really a genetic component," Freiermuth says. "We're starting to hone down what the genetic component is and we could get to a point in the future when we could run tests and if you have opioid use disorder, we could run the test on you and we could run it on your children so that we could counsel people in the future that they may also be at risk."
Read more about the research here.
Lead photo of Caroline Freiermuth, MD/Colleen Kelley/UC Marketing + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.